nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—DRD2—nicotine dependence	0.72	1	CbGaD
Rotigotine—Terminal insomnia—Varenicline—nicotine dependence	0.0233	0.156	CcSEcCtD
Rotigotine—DRD5—Dopamine receptors—DRD2—nicotine dependence	0.00752	0.0575	CbGpPWpGaD
Rotigotine—Sinus congestion—Varenicline—nicotine dependence	0.00587	0.0393	CcSEcCtD
Rotigotine—DRD4—Dopamine receptors—DRD2—nicotine dependence	0.00555	0.0425	CbGpPWpGaD
Rotigotine—Balance disorder—Varenicline—nicotine dependence	0.00534	0.0358	CcSEcCtD
Rotigotine—DRD4—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.00515	0.0394	CbGpPWpGaD
Rotigotine—DRD1—Dopamine receptors—DRD2—nicotine dependence	0.005	0.0382	CbGpPWpGaD
Rotigotine—DRD3—Dopamine receptors—DRD2—nicotine dependence	0.00493	0.0377	CbGpPWpGaD
Rotigotine—Libido increased—Varenicline—nicotine dependence	0.0048	0.0321	CcSEcCtD
Rotigotine—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.00457	0.035	CbGpPWpGaD
Rotigotine—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.00433	0.029	CcSEcCtD
Rotigotine—Laryngeal pain—Varenicline—nicotine dependence	0.00429	0.0287	CcSEcCtD
Rotigotine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.0035	0.0268	CbGpPWpGaD
Rotigotine—Aggression—Varenicline—nicotine dependence	0.00333	0.0222	CcSEcCtD
Rotigotine—DRD4—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00332	0.0254	CbGpPWpGaD
Rotigotine—Musculoskeletal pain—Varenicline—nicotine dependence	0.00296	0.0198	CcSEcCtD
Rotigotine—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00295	0.0226	CbGpPWpGaD
Rotigotine—Abnormal dreams—Varenicline—nicotine dependence	0.00289	0.0193	CcSEcCtD
Rotigotine—Nightmare—Varenicline—nicotine dependence	0.00282	0.0189	CcSEcCtD
Rotigotine—DRD4—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.00271	0.0207	CbGpPWpGaD
Rotigotine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00248	0.0189	CbGpPWpGaD
Rotigotine—Sleep disorder—Varenicline—nicotine dependence	0.00245	0.0164	CcSEcCtD
Rotigotine—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.0024	0.0184	CbGpPWpGaD
Rotigotine—DRD4—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00238	0.0182	CbGpPWpGaD
Rotigotine—Disorientation—Varenicline—nicotine dependence	0.00237	0.0159	CcSEcCtD
Rotigotine—Eczema—Varenicline—nicotine dependence	0.00236	0.0158	CcSEcCtD
Rotigotine—Hot flush—Varenicline—nicotine dependence	0.00227	0.0152	CcSEcCtD
Rotigotine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00226	0.0173	CbGpPWpGaD
Rotigotine—Menopausal symptoms—Varenicline—nicotine dependence	0.00225	0.015	CcSEcCtD
Rotigotine—Lethargy—Varenicline—nicotine dependence	0.00216	0.0145	CcSEcCtD
Rotigotine—DRD4—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.00216	0.0165	CbGpPWpGaD
Rotigotine—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00212	0.0162	CbGpPWpGaD
Rotigotine—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.0021	0.0141	CcSEcCtD
Rotigotine—Psychotic disorder—Varenicline—nicotine dependence	0.00207	0.0139	CcSEcCtD
Rotigotine—Irritability—Varenicline—nicotine dependence	0.00202	0.0135	CcSEcCtD
Rotigotine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00193	0.0148	CbGpPWpGaD
Rotigotine—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.00192	0.0147	CbGpPWpGaD
Rotigotine—Breast disorder—Varenicline—nicotine dependence	0.00192	0.0128	CcSEcCtD
Rotigotine—Nasopharyngitis—Varenicline—nicotine dependence	0.0019	0.0127	CcSEcCtD
Rotigotine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.00184	0.0141	CbGpPWpGaD
Rotigotine—DRD4—Nicotine Activity on Dopaminergic Neurons—DRD2—nicotine dependence	0.00176	0.0135	CbGpPWpGaD
Rotigotine—Erectile dysfunction—Varenicline—nicotine dependence	0.00169	0.0113	CcSEcCtD
Rotigotine—Weight increased—Varenicline—nicotine dependence	0.00167	0.0112	CcSEcCtD
Rotigotine—DRD5—Monoamine GPCRs—DRD2—nicotine dependence	0.00166	0.0127	CbGpPWpGaD
Rotigotine—Infestation NOS—Varenicline—nicotine dependence	0.00163	0.0109	CcSEcCtD
Rotigotine—Infestation—Varenicline—nicotine dependence	0.00163	0.0109	CcSEcCtD
Rotigotine—Depression—Varenicline—nicotine dependence	0.00163	0.0109	CcSEcCtD
Rotigotine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00162	0.0124	CbGpPWpGaD
Rotigotine—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD2—nicotine dependence	0.00156	0.012	CbGpPWpGaD
Rotigotine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00153	0.0117	CbGpPWpGaD
Rotigotine—Sinusitis—Varenicline—nicotine dependence	0.00153	0.0103	CcSEcCtD
Rotigotine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.00147	0.0112	CbGpPWpGaD
Rotigotine—Hallucination—Varenicline—nicotine dependence	0.00146	0.00977	CcSEcCtD
Rotigotine—Oedema peripheral—Varenicline—nicotine dependence	0.00145	0.00967	CcSEcCtD
Rotigotine—Connective tissue disorder—Varenicline—nicotine dependence	0.00144	0.00965	CcSEcCtD
Rotigotine—Visual impairment—Varenicline—nicotine dependence	0.00141	0.00946	CcSEcCtD
Rotigotine—DRD5—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0014	0.0107	CbGpPWpGaD
Rotigotine—Tinnitus—Varenicline—nicotine dependence	0.00137	0.00915	CcSEcCtD
Rotigotine—Angiopathy—Varenicline—nicotine dependence	0.00133	0.00891	CcSEcCtD
Rotigotine—Immune system disorder—Varenicline—nicotine dependence	0.00133	0.00887	CcSEcCtD
Rotigotine—Mediastinal disorder—Varenicline—nicotine dependence	0.00132	0.00885	CcSEcCtD
Rotigotine—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.0013	0.00995	CbGpPWpGaD
Rotigotine—Mental disorder—Varenicline—nicotine dependence	0.00129	0.0086	CcSEcCtD
Rotigotine—Malnutrition—Varenicline—nicotine dependence	0.00128	0.00855	CcSEcCtD
Rotigotine—Erythema—Varenicline—nicotine dependence	0.00128	0.00855	CcSEcCtD
Rotigotine—DRD4—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.00126	0.00962	CbGpPWpGaD
Rotigotine—Muscle spasms—Varenicline—nicotine dependence	0.00123	0.00822	CcSEcCtD
Rotigotine—DRD4—Monoamine GPCRs—DRD2—nicotine dependence	0.00123	0.00938	CbGpPWpGaD
Rotigotine—Tremor—Varenicline—nicotine dependence	0.0012	0.00801	CcSEcCtD
Rotigotine—Ill-defined disorder—Varenicline—nicotine dependence	0.00119	0.00793	CcSEcCtD
Rotigotine—Agitation—Varenicline—nicotine dependence	0.00117	0.00785	CcSEcCtD
Rotigotine—Angioedema—Varenicline—nicotine dependence	0.00117	0.00781	CcSEcCtD
Rotigotine—Malaise—Varenicline—nicotine dependence	0.00115	0.00771	CcSEcCtD
Rotigotine—Vertigo—Varenicline—nicotine dependence	0.00115	0.00768	CcSEcCtD
Rotigotine—Syncope—Varenicline—nicotine dependence	0.00115	0.00766	CcSEcCtD
Rotigotine—DRD1—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.00113	0.00866	CbGpPWpGaD
Rotigotine—Loss of consciousness—Varenicline—nicotine dependence	0.00112	0.00751	CcSEcCtD
Rotigotine—Cough—Varenicline—nicotine dependence	0.00111	0.00746	CcSEcCtD
Rotigotine—DRD1—Monoamine GPCRs—DRD2—nicotine dependence	0.0011	0.00845	CbGpPWpGaD
Rotigotine—Hypertension—Varenicline—nicotine dependence	0.0011	0.00738	CcSEcCtD
Rotigotine—DRD3—Monoamine GPCRs—DRD2—nicotine dependence	0.00109	0.00834	CbGpPWpGaD
Rotigotine—Arthralgia—Varenicline—nicotine dependence	0.00109	0.00727	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00108	0.00722	CcSEcCtD
Rotigotine—Discomfort—Varenicline—nicotine dependence	0.00107	0.00719	CcSEcCtD
Rotigotine—Dry mouth—Varenicline—nicotine dependence	0.00106	0.00711	CcSEcCtD
Rotigotine—Infection—Varenicline—nicotine dependence	0.00104	0.00693	CcSEcCtD
Rotigotine—DRD4—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00103	0.00789	CbGpPWpGaD
Rotigotine—Shock—Varenicline—nicotine dependence	0.00103	0.00686	CcSEcCtD
Rotigotine—Nervous system disorder—Varenicline—nicotine dependence	0.00102	0.00684	CcSEcCtD
Rotigotine—Skin disorder—Varenicline—nicotine dependence	0.00101	0.00677	CcSEcCtD
Rotigotine—Hyperhidrosis—Varenicline—nicotine dependence	0.00101	0.00674	CcSEcCtD
Rotigotine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.001	0.00768	CbGpPWpGaD
Rotigotine—Anorexia—Varenicline—nicotine dependence	0.000994	0.00665	CcSEcCtD
Rotigotine—ADRA2B—Monoamine GPCRs—DRD2—nicotine dependence	0.000984	0.00753	CbGpPWpGaD
Rotigotine—Hypotension—Varenicline—nicotine dependence	0.000974	0.00652	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00095	0.00635	CcSEcCtD
Rotigotine—HTR1A—Monoamine GPCRs—DRD2—nicotine dependence	0.00095	0.00726	CbGpPWpGaD
Rotigotine—Insomnia—Varenicline—nicotine dependence	0.000943	0.00631	CcSEcCtD
Rotigotine—DRD1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000928	0.0071	CbGpPWpGaD
Rotigotine—Somnolence—Varenicline—nicotine dependence	0.000927	0.0062	CcSEcCtD
Rotigotine—Dyspepsia—Varenicline—nicotine dependence	0.000918	0.00614	CcSEcCtD
Rotigotine—DRD3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000916	0.00701	CbGpPWpGaD
Rotigotine—Decreased appetite—Varenicline—nicotine dependence	0.000906	0.00606	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.0009	0.00602	CcSEcCtD
Rotigotine—Fatigue—Varenicline—nicotine dependence	0.000899	0.00601	CcSEcCtD
Rotigotine—Pain—Varenicline—nicotine dependence	0.000891	0.00596	CcSEcCtD
Rotigotine—Constipation—Varenicline—nicotine dependence	0.000891	0.00596	CcSEcCtD
Rotigotine—Feeling abnormal—Varenicline—nicotine dependence	0.000859	0.00575	CcSEcCtD
Rotigotine—DRD4—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000837	0.0064	CbGpPWpGaD
Rotigotine—Urticaria—Varenicline—nicotine dependence	0.000828	0.00554	CcSEcCtD
Rotigotine—ADRA2B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000827	0.00633	CbGpPWpGaD
Rotigotine—HTR1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000798	0.00611	CbGpPWpGaD
Rotigotine—Hypersensitivity—Varenicline—nicotine dependence	0.000768	0.00514	CcSEcCtD
Rotigotine—Asthenia—Varenicline—nicotine dependence	0.000748	0.005	CcSEcCtD
Rotigotine—DRD3—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000743	0.00569	CbGpPWpGaD
Rotigotine—Pruritus—Varenicline—nicotine dependence	0.000737	0.00493	CcSEcCtD
Rotigotine—Diarrhoea—Varenicline—nicotine dependence	0.000713	0.00477	CcSEcCtD
Rotigotine—Dizziness—Varenicline—nicotine dependence	0.000689	0.00461	CcSEcCtD
Rotigotine—DRD5—GPCR ligand binding—TAS2R16—nicotine dependence	0.000687	0.00525	CbGpPWpGaD
Rotigotine—ADRA2B—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000671	0.00513	CbGpPWpGaD
Rotigotine—Vomiting—Varenicline—nicotine dependence	0.000663	0.00443	CcSEcCtD
Rotigotine—Rash—Varenicline—nicotine dependence	0.000657	0.0044	CcSEcCtD
Rotigotine—Dermatitis—Varenicline—nicotine dependence	0.000657	0.00439	CcSEcCtD
Rotigotine—Headache—Varenicline—nicotine dependence	0.000653	0.00437	CcSEcCtD
Rotigotine—HTR1A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000648	0.00496	CbGpPWpGaD
Rotigotine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000637	0.00488	CbGpPWpGaD
Rotigotine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000629	0.00481	CbGpPWpGaD
Rotigotine—Nausea—Varenicline—nicotine dependence	0.000619	0.00414	CcSEcCtD
Rotigotine—DRD2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000569	0.00435	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000556	0.00425	CbGpPWpGaD
Rotigotine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00054	0.00413	CbGpPWpGaD
Rotigotine—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000533	0.00408	CbGpPWpGaD
Rotigotine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000517	0.00395	CbGpPWpGaD
Rotigotine—DRD4—GPCR ligand binding—TAS2R16—nicotine dependence	0.000507	0.00388	CbGpPWpGaD
Rotigotine—DRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000456	0.00349	CbGpPWpGaD
Rotigotine—DRD3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00045	0.00344	CbGpPWpGaD
Rotigotine—DRD5—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000444	0.00339	CbGpPWpGaD
Rotigotine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000438	0.00335	CbGpPWpGaD
Rotigotine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000417	0.00319	CbGpPWpGaD
Rotigotine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000411	0.00315	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.000406	0.00311	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000392	0.003	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000391	0.00299	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000388	0.00297	CbGpPWpGaD
Rotigotine—DRD5—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00038	0.00291	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000371	0.00284	CbGpPWpGaD
Rotigotine—DRD4—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000353	0.0027	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—TAS2R16—nicotine dependence	0.000352	0.0027	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000352	0.00269	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000347	0.00266	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000344	0.00263	CbGpPWpGaD
Rotigotine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000338	0.00258	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000337	0.00257	CbGpPWpGaD
Rotigotine—DRD4—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000327	0.0025	CbGpPWpGaD
Rotigotine—DRD5—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000321	0.00245	CbGpPWpGaD
Rotigotine—DRD3—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000313	0.0024	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—FGD1—nicotine dependence	0.000304	0.00233	CbGpPWpGaD
Rotigotine—DRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000295	0.00226	CbGpPWpGaD
Rotigotine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000291	0.00223	CbGpPWpGaD
Rotigotine—DRD3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000291	0.00222	CbGpPWpGaD
Rotigotine—DRD5—GPCR ligand binding—OPRM1—nicotine dependence	0.000289	0.00221	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—DRD2—nicotine dependence	0.000289	0.00221	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000286	0.00219	CbGpPWpGaD
Rotigotine—ADRA2B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000283	0.00216	CbGpPWpGaD
Rotigotine—DRD4—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000281	0.00215	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—FGD1—nicotine dependence	0.000276	0.00212	CbGpPWpGaD
Rotigotine—DRD5—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000275	0.0021	CbGpPWpGaD
Rotigotine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000274	0.0021	CbGpPWpGaD
Rotigotine—HTR1A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000273	0.00209	CbGpPWpGaD
Rotigotine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000271	0.00207	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000266	0.00203	CbGpPWpGaD
Rotigotine—ADRA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000263	0.00201	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—DRD2—nicotine dependence	0.00026	0.00199	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—TAS2R16—nicotine dependence	0.00026	0.00199	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000258	0.00197	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—DRD2—nicotine dependence	0.000257	0.00196	CbGpPWpGaD
Rotigotine—DRD4—G alpha (i) signalling events—DRD2—nicotine dependence	0.000255	0.00195	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000254	0.00195	CbGpPWpGaD
Rotigotine—HTR1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000253	0.00194	CbGpPWpGaD
Rotigotine—DRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000253	0.00193	CbGpPWpGaD
Rotigotine—DRD3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000249	0.00191	CbGpPWpGaD
Rotigotine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000247	0.00189	CbGpPWpGaD
Rotigotine—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00024	0.00183	CbGpPWpGaD
Rotigotine—DRD4—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000237	0.00181	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000234	0.00179	CbGpPWpGaD
Rotigotine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000233	0.00178	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—TAS2R16—nicotine dependence	0.000231	0.00177	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00023	0.00176	CbGpPWpGaD
Rotigotine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000229	0.00175	CbGpPWpGaD
Rotigotine—DRD3—G alpha (i) signalling events—DRD2—nicotine dependence	0.000227	0.00173	CbGpPWpGaD
Rotigotine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000225	0.00172	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—FGD1—nicotine dependence	0.000225	0.00172	CbGpPWpGaD
Rotigotine—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000223	0.0017	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000222	0.0017	CbGpPWpGaD
Rotigotine—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000217	0.00166	CbGpPWpGaD
Rotigotine—DRD4—GPCR ligand binding—OPRM1—nicotine dependence	0.000214	0.00163	CbGpPWpGaD
Rotigotine—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000213	0.00163	CbGpPWpGaD
Rotigotine—DRD3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00021	0.00161	CbGpPWpGaD
Rotigotine—DRD5—GPCR ligand binding—DRD2—nicotine dependence	0.000209	0.0016	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000209	0.0016	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TAS2R16—nicotine dependence	0.000208	0.00159	CbGpPWpGaD
Rotigotine—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.000205	0.00156	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—FGD1—nicotine dependence	0.000204	0.00156	CbGpPWpGaD
Rotigotine—DRD4—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000203	0.00155	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000202	0.00155	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000201	0.00154	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—FGD1—nicotine dependence	0.0002	0.00153	CbGpPWpGaD
Rotigotine—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000197	0.00151	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000195	0.00149	CbGpPWpGaD
Rotigotine—DRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.000192	0.00147	CbGpPWpGaD
Rotigotine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000191	0.00146	CbGpPWpGaD
Rotigotine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00019	0.00146	CbGpPWpGaD
Rotigotine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00019	0.00145	CbGpPWpGaD
Rotigotine—DRD3—GPCR ligand binding—OPRM1—nicotine dependence	0.00019	0.00145	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000184	0.00141	CbGpPWpGaD
Rotigotine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000183	0.0014	CbGpPWpGaD
Rotigotine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000183	0.0014	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—FGD1—nicotine dependence	0.000181	0.00139	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.00018	0.00138	CbGpPWpGaD
Rotigotine—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00018	0.00138	CbGpPWpGaD
Rotigotine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000179	0.00137	CbGpPWpGaD
Rotigotine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000177	0.00135	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000177	0.00135	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000174	0.00133	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000171	0.00131	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000165	0.00127	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.000164	0.00125	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—OPRM1—nicotine dependence	0.000164	0.00125	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—FGD1—nicotine dependence	0.000163	0.00125	CbGpPWpGaD
Rotigotine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000163	0.00124	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000158	0.00121	CbGpPWpGaD
Rotigotine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000157	0.0012	CbGpPWpGaD
Rotigotine—DRD4—GPCR ligand binding—DRD2—nicotine dependence	0.000154	0.00118	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TAS2R16—nicotine dependence	0.000154	0.00118	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000153	0.00117	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—OPRM1—nicotine dependence	0.000149	0.00114	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000145	0.00111	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKR1B10—nicotine dependence	0.000144	0.0011	CbGpPWpGaD
Rotigotine—DRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000139	0.00106	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000139	0.00106	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000138	0.00106	CbGpPWpGaD
Rotigotine—DRD3—GPCR ligand binding—DRD2—nicotine dependence	0.000137	0.00105	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TAS2R16—nicotine dependence	0.000136	0.00104	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	0.000124	0.000948	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000123	0.000942	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—OPRM1—nicotine dependence	0.000121	0.000924	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—FGD1—nicotine dependence	0.000121	0.000922	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	0.00012	0.000915	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000119	0.00091	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—DRD2—nicotine dependence	0.000118	0.000905	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—OPRM1—nicotine dependence	0.00011	0.000839	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000109	0.000831	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—FGD1—nicotine dependence	0.000109	0.00083	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—DRD2—nicotine dependence	0.000107	0.000822	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—OPRM1—nicotine dependence	0.000107	0.00082	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—FGD1—nicotine dependence	0.000107	0.000819	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AKR1B10—nicotine dependence	0.000106	0.000815	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.000104	0.000799	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—WASF2—nicotine dependence	0.000102	0.000778	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	9.87e-05	0.000755	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—WASF1—nicotine dependence	9.75e-05	0.000746	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—OPRM1—nicotine dependence	9.74e-05	0.000745	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	9.68e-05	0.000741	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	9.67e-05	0.00074	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	9.59e-05	0.000733	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKR1B10—nicotine dependence	9.46e-05	0.000724	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	9.35e-05	0.000715	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—FGD1—nicotine dependence	9.33e-05	0.000714	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	8.79e-05	0.000673	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—OPRM1—nicotine dependence	8.77e-05	0.000671	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—DRD2—nicotine dependence	8.73e-05	0.000668	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	8.54e-05	0.000653	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	8.49e-05	0.000649	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	8.24e-05	0.000631	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	8.21e-05	0.000628	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—FGD1—nicotine dependence	8.19e-05	0.000627	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—DRD2—nicotine dependence	7.93e-05	0.000606	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	7.86e-05	0.000601	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—DRD2—nicotine dependence	7.75e-05	0.000593	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—WASF2—nicotine dependence	7.5e-05	0.000574	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	7.45e-05	0.00057	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	7.24e-05	0.000554	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—WASF1—nicotine dependence	7.19e-05	0.00055	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—DRD2—nicotine dependence	7.14e-05	0.000546	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—DRD2—nicotine dependence	7.04e-05	0.000539	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	7e-05	0.000535	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	6.76e-05	0.000517	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—WASF2—nicotine dependence	6.75e-05	0.000517	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—WASF2—nicotine dependence	6.66e-05	0.00051	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—OPRM1—nicotine dependence	6.48e-05	0.000495	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—WASF1—nicotine dependence	6.48e-05	0.000495	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—WASF1—nicotine dependence	6.39e-05	0.000489	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	6.36e-05	0.000486	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—DRD2—nicotine dependence	6.34e-05	0.000485	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	6.14e-05	0.000469	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	6.02e-05	0.00046	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—OPRM1—nicotine dependence	5.83e-05	0.000446	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—WASF2—nicotine dependence	5.81e-05	0.000444	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	5.77e-05	0.000441	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—OPRM1—nicotine dependence	5.75e-05	0.00044	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—WASF1—nicotine dependence	5.57e-05	0.000426	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	5.19e-05	0.000397	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—WASF2—nicotine dependence	5.1e-05	0.00039	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	5.01e-05	0.000384	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—WASF1—nicotine dependence	4.89e-05	0.000374	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	4.69e-05	0.000359	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—DRD2—nicotine dependence	4.68e-05	0.000358	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	4.4e-05	0.000337	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—DRD2—nicotine dependence	4.22e-05	0.000322	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—DRD2—nicotine dependence	4.16e-05	0.000318	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	3.98e-05	0.000304	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	3.75e-05	0.000287	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—DRD2—nicotine dependence	3.62e-05	0.000277	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	3.07e-05	0.000235	CbGpPWpGaD
